Wegovy comes in doses of 0.25, 0.5, 1.0, 1.7, and 2.4 milligrams, escalated every 4 weeks to a maintenance dose of 2.4 milligrams
Obesity is defined as a BMI of 30 or above, while a BMI of 25 or above is considered overweight
A recent trial that enrolled over 17,000 participants demonstrated that Wegovy reduced the risk of heart attack, stroke and cardiovascular disease by 20% compared to placebo
PlexusDx can provide prescription documentation via telehealth if you need to travel on short noticesimply request it before your flight date
Although the drug met its primary endpoint of achieving a statistically significant weight reduction compared to placebo, the results fell short of the 25% weight loss target that Novo had been pitching to investors
Receptor selectivity, tissue exposure, formulation, dose, timing, model choice, and safety signals all sit upstream